Volume Overload Clinical Trial
Zero Sodium Peritoneal Dialysate Protocol in Human Pilot Study
The following pilot study will be undertaken to determine the effects of use of a zero-sodium peritoneal dialysate solution (10% dextrose in sterile water) on sodium removal as compared to a standard peritoneal dialysis solution.
While heart failure (HF) is generally regarded as the inability of the heart to pump sufficient blood, on a population level, volume overload is the primary driver of morbidity and hospitalization. The signs and symptoms of volume overload are driven by water accumulation, which is initially driven by sodium retention. This overall goal of this study is to investigate the ability to remove sodium through use of a zero-sodium solution in peritoneal dialysis. ;
|Contact||Devin D Mahoney|
|Phase||Early Phase 1|
|Start date||December 1, 2018|
|Completion date||December 31, 2020|